Literature DB >> 22511265

Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.

Shiow-Ching Shun1, Chien-Hung Chen, Jin-Chuan Sheu, Ja-Der Liang, Jyh-Chin Yang, Yeur-Hur Lai.   

Abstract

OBJECTIVE: To (a) explore changes in physical and psychological distress and quality of life (QOL) and (b) identify the significant pre- and postdischarge factors related to changes in physical and mental domains of QOL over a period of 2 months in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization (TACE) treatment.
METHODS: A longitudinal prospective design was used, with participants recruited from a teaching hospital in Northern Taiwan. Data were collected three times: within 3 days prior to discharge (T0) and at the fourth (T1) and eighth (T2) weeks after discharge. A set of structured questionnaires was used to assess participants' QOL, symptom distress, anxiety, and depression. Changes in QOL and associated factors were examined using generalized estimating equations.
RESULTS: Eighty-nine patients were included in this study. Fatigue was reported to be the most distressful symptom after treatment. Overall QOL improved monthly after discharge. Change in physical QOL 2 months after TACE treatment was associated with age, diagnosis status, level of symptom distress, and depression after discharge. Change in mental QOL was significantly associated with gender, diagnosis status, and anxiety and depression after discharge.
CONCLUSIONS: Health care providers should pay special attention to patients of older age, those who are male, and those who have higher levels of depression and anxiety after discharge. Designing personalized education programs before discharge for patients with newly diagnosed cancer versus those who have recurrent disease is suggested to help patients maintain a better QOL after discharge.

Entities:  

Mesh:

Year:  2012        PMID: 22511265      PMCID: PMC3360913          DOI: 10.1634/theoncologist.2011-0368

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  42 in total

1.  Anxiety and depression in Taiwanese cancer patients with and without pain.

Authors:  M L Chen; H K Chang; C H Yeh
Journal:  J Adv Nurs       Date:  2000-10       Impact factor: 3.187

Review 2.  Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma.

Authors:  Tito Livraghi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

Review 3.  Exercise programs for cancer-related fatigue: evidence and clinical guidelines.

Authors:  Margaret L McNeely; Kerry S Courneya
Journal:  J Natl Compr Canc Netw       Date:  2010-08       Impact factor: 11.908

4.  Development of a symptom distress scale.

Authors:  R McCorkle; K Young
Journal:  Cancer Nurs       Date:  1978-10       Impact factor: 2.592

5.  Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization.

Authors:  Brandt C Wible; William S Rilling; Peter Drescher; Robert A Hieb; Kia Saeian; Constantine Frangakis; Yong Chen; Daniel Eastwood; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2010-06-04       Impact factor: 3.464

Review 6.  Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

Authors:  F Trevisani; S De Notariis; C Rossi; M Bernardi
Journal:  J Clin Gastroenterol       Date:  2001 May-Jun       Impact factor: 3.062

Review 7.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Reduced quality of life of patients with hepatocellular carcinoma.

Authors:  G Bianchi; C Loguercio; D Sgarbi; R Abbiati; N Brunetti; T De Simone; M Zoli; G Marchesini
Journal:  Dig Liver Dis       Date:  2003-01       Impact factor: 4.088

9.  Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire.

Authors:  Steven D Passik; Kenneth L Kirsh; Kathleen Donaghy; Elizabeth Holtsclaw; Dale Theobald; David Cella; William Breitbart
Journal:  J Pain Symptom Manage       Date:  2002-11       Impact factor: 3.612

10.  Symptom distress, catastrophic thinking, and hope in nasopharyngeal carcinoma patients.

Authors:  Yeur-Hur Lai; Joseph Tung-Chien Chang; Francis J Keefe; Chung-Fong Chiou; Shu-Ching Chen; Shu-Chin Feng; Su-Jene Dou; Mei-Nan Liao
Journal:  Cancer Nurs       Date:  2003-12       Impact factor: 2.592

View more
  13 in total

1.  Prognostic association of demographic and clinical factors with the change rates of symptoms and depression among patients with hepatocellular carcinoma.

Authors:  Jyh-Jou Chen; Sheng-Shiung Huang; In-Fun Li; Kuan-Pin Lin; Shiow-Luan Tsay
Journal:  Support Care Cancer       Date:  2019-04-03       Impact factor: 3.603

Review 2.  Quality of life and hepatocellular carcinoma.

Authors:  Shipra Gandhi; Sapna Khubchandani; Renuka Iyer
Journal:  J Gastrointest Oncol       Date:  2014-08

3.  Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC.

Authors:  K J Hartrumpf; S Marquardt; T Werncke; T Murray; M M Kirstein; A Vogel; F Wacker; T Rodt
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-14       Impact factor: 4.553

Review 4.  Incorporating Quality of Life Metrics in Interventional Oncology Practice.

Authors:  David Li; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

5.  Impact of surgery on quality of life in patients with hepatocellular carcinoma.

Authors:  Yoshihiro Mise; Shouichi Satou; Takeaki Ishizawa; Junichi Kaneko; Taku Aoki; Kiyoshi Hasegawa; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

6.  Putting the "Person" in Personalized Cancer Medicine: A Systematic Review of Psychological Aspects of Targeted Therapy.

Authors:  Daniel C McFarland; Jada G Hamilton; Rosanne Fox; Jimmie Holland
Journal:  Pers Med Oncol       Date:  2014-12

7.  Effects of acupressure on fatigue and depression in hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization: a quasi-experimental study.

Authors:  Su-Chen Lan; Yueh-E Lin; Shu-Ching Chen; Yu-Fang Lin; Yu-Jen Wang
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

Review 8.  Value of quality of life analysis in liver cancer: A clinician's perspective.

Authors:  Leung Li; Winnie Yeo
Journal:  World J Hepatol       Date:  2017-07-18

Review 9.  Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization.

Authors:  Saleem Ahmed; Nurun Nisa de Souza; Wang Qiao; Meidai Kasai; Low Jee Keem; Vishal G Shelat
Journal:  HPB Surg       Date:  2016-04-07

10.  Elevated systemic inflammatory responses, factors associated with physical and mental quality of life, and prognosis of hepatocellular carcinoma.

Authors:  Yang Deng; Jian Zhu; Ziyi Liu; Maosheng Huang; David W Chang; Jian Gu
Journal:  Aging (Albany NY)       Date:  2020-03-07       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.